Roche to acquire COVID Test Maker GenMark for $1.8B

“Together with Roche’s diagnostics healthcare solutions, we will be able to provide a full suite of molecular diagnostic solutions to customers around the world.”

- Scott Mendel, CEO of GenMark

Deal Overview

- Acquirer: Roche (SWX: RO)

- Target: GenMark (NASDAQ: GNMK)

- Industry: Medical Diagnostics

- Transaction Amount: $1.8B

- Announcement Date: March 15, 2021

- Target Advisor: J.P. Morgan

- Acquirer Advisor: Citi

Roche_GenMark_LaTex

.pdf

Download PDF • 309KB